Glaxosmithkline Share News (GSK)

Weak lung drug sales and strong pound hit GlaxoSmithKline

LONDON, July 23 (Reuters) - GlaxoSmithKline's sales fell by a worse-than-expected 13 percent in the second quarter as its all-important lung drugs struggled in the United States and a strong pound took a bite out of growth. A run of weak quarters highlights the pressure on Chief Executive A

MARKET COMMENT: UK Stocks Up, While Pound Retreats On BoE Minutes

MARKET COMMENT: UK Shares To Open Lower Ahead Of BoE Minutes

UK Earnings, Trading Statements Calendar - Week Ahead

MARKET COMMENT: UK Stocks Gain Amid EU Indecision On Russia Sanctions

Wednesday preview: GSK results, BoE meeting minutes

GlaxoSmithKline (GSK) reports its second quarter interims on Wednesday amid an investigation over a bribery scandal in China. Panmure Gordon said it is "not expecting fireworks" from GSK's results. "In light of our recent downgrade to forecasts due to exchange rate headwinds, we are expecting anoth

UK Earnings, Trading Statements Calendar - Week Ahead

UK Earnings, Trading Statements Calendar - Week Ahead

PRESS: Lupin, US Firms Weighing Bids For Glaxo's Mature Drugs - Reuters

UK WINNERS & LOSERS: ARM Leads FTSE 100 As Tesco Gives Back Gains

Glaxo Says ViiV Phase III Maraviroc Study Shows Inferior Efficacy

UK Earnings, Trading Statements Calendar - Week Ahead

Drugmakers to share neglected compounds with British academia

LONDON, July 22 (Reuters) - A group of seven leading drugmakers has agreed to share an array of neglected experimental medicines with British academic researchers in the latest example of the deepening ties between industry and external scientists. British business minister Vince Cable anno

DIRECTOR DEALINGS: GlaxoSmithKline Directors Buy Shares

UK Earnings, Trading Statements Calendar - Week Ahead